chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a certified medical assistant refers to unspecified number of patients of unknown age and gender. There were no concurrent conditions, medical histories or concomitant therapies reported. On an unknown date, the patients were vaccinated with doses of improperly stored (Oka/Merck) VARIVAX (lot number: L007227, expiration date: 03-MAR-2017), (lot number: L008272, expiration date: 11-MAR-2017), (lot number: L004650, expiration date: 11-FEB-2017) (dose, route of administration unspecified). No adverse effects were reported. Additional information has been requested.
This spontaneous report as received from a nurse, refers to a currently 16 year old patient of unknown gender. No pertinent medical history, drug reactions/ allergies or concurrent conditions were reported. On an unknown date, the patient was vaccinated with a dose of improperly stored GARDASIL 9 (which had a lot # of R001262 and an expiration date of 10-NOV-2001; however, dosage number and route of administration were not reported), for prophylaxis. Nonetheless, no adverse effects were reported. The vaccine experienced the following potential temperature excursion: Unknown temperature for 1 day. Reportedly, there had been no previous temperature excursions and the aforementioned one were not  identified due to a data logger. Furthermore, no product quality complaint was involved. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1807USA011814; US-009507513-1807USA011815; US-009507513-1807USA008554.
Immunization was administered in left arm.  Patient then passed out & was laid down.  Pt was drooling, then her legs & arms extended outward (straight) with contracted flexed fingers.  Total episode last approx. 5-10 seconds.  Patient was dizzy afterwards & could not recall the incident.
Information has been received from a pharmacist concerning a 13 year old female with allergic reaction to AUGMENTIN and cephalosporin (reported as cephlosporin) who on 22-JAN-2008 was vaccinated with a first dose of Gardasil (Lot # 659657/1487U) and was vaccinated with a dose of MENACTRA.  With in hours of receiving the first dose of Gardasil, on 22-JAN-2008, the patient developed hives all over her body.  No treatment Information was provided.  It was reported that after 4 days on 26-JAN-2008, the patient recovered from her hives.  It was reported that the patient had not had previous exposure to this or related drug, and the patient is not pregnant.  No further information is available.
administrated Pediarix and a single dose of IPV at the same time; This case was reported by a physician via call center representative and described the occurrence of overdose in a 6-month-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number 4977t, expiry date 5th September 2022) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis and POLIOMYELITIS VACCINE INACTIVATED (IPV (INACTIVATED POLIO VACCINE)) for prophylaxis.   On 23rd August 2021, the patient received the 3rd dose of Pediarix, Pediarix Pre-Filled Syringe Device and IPV (INACTIVATED POLIO VACCINE). On 23rd August 2021, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced overdose. On an unknown date, the outcome of the overdose was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The patient reported that 6 month old male patient was administrated Pediarix and a single dose of IPV at the same time, which led to overdose for inactivated polio component. The vaccines were administrated on the same day.  The dose of Pediarix was meant to be a third dose. The injections were given each one in different legs. The HCP believed the single dose IPV was from the brand SANOFI  but was not sure. No further events were reported. The reporter agreed to be contacted for follow up through email.
Patient received Bexsero vaccine on 05/14/2020. On  05/15/2020 morning arm felt sore. On 05/16, 05/17  arm painful ,swollen and warm. 05/18/2020 Patient had virtual appointment with DR, was prescribed hydrocortisone 2.5% twice daily.
Bell's Palsy /  Can't smile / Can't wink/blink his left eye; He isn't pronouncing his words clearly; can't wink/blink his left eye; This case was reported by a consumer via call center representative and described the occurrence of bell's palsy in a 51-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 23rd Mrach 2020 on unknown deltiod via intramuscular route).   On 26th May 2020, the patient received the 2nd dose of Shingrix (intramuscular). On 5th November 2020, 163 days after receiving Shingrix, the patient experienced bell's palsy (serious criteria GSK medically significant). In November 2020, the patient experienced dysarthria and eyelid function disorder. The patient was treated with prednisone. On an unknown date, the outcome of the bell's palsy was not recovered/not resolved and the outcome of the dysarthria and eyelid function disorder were unknown.   The reporter considered the bell's palsy, dysarthria and eyelid function disorder to be related to Shingrix.  Additional details were reported as follows: The patient reported the case by himself. The patient received 2nd dose of Shingrix on deltoid muscle at MD office. The patient began to noticing symptoms involving the left side of his case on 5th November 2020. On 9th November 2020, the patient went to the physician's office and was diagnosed with the Bell's Palsy. The patient was prescribed Prednisone 60 milligram daily for 7 days. The patient's condition was not improving it was about the same. The patient's wife said that she thought it look like the patient face was improving. The patient stated that he could not smile or wink or blink his left eye. The patient could only close his left eye if he closes both eyes. The reporter believed his bell's palsy was side effect of Shingrix. At the time of call, the physician mentioned that if he had trouble understanding of patient or he was not pronouncing his words clearly it was because of the Bell's palsy. The reporter consented to follow up.
14 hours after booster shot headache, muscle aches, dizziness.   Dizziness is continuing 48+ hours after.
59 y.o presented with  weakness, hypotension and bradycardia about 10 mins post covid vaccination. patient transient and unable to easily access medical care or obtain meds for pre-existing conditions. Pt would brady down in the upper 30's lower 40's. 10:31 62/39 p 41 r 16 glucose 252 10:34 76/51 p 51 r 16 10:44 91/58 p 52 r 16 10:48 99/64 p 50 r 16 10:54 108/68 p 56 r 16 Pt transported to Hospital.
Vaccine was administered on 12/30 at around noon.  I felt fine that day but was aware that a previously diagnosed but inactive area of contact dermatitis on my right knee was flaring up - becoming very pruritic and active.  Over about 48 hours it became red, blistered and eventually weepy.  The area had been biopsied in September of 2020 ("spongiatic dermatitis"), treated with topical steroids and for the most part resolved.  I saw my dermatologist on 1/6 - repeat biopsy was done ("severe allergic reaction") and it was treated again with topical steroids and is resolving.  On 1/12 I began experiencing generalized pruritus.  I have patchy erythema, dermatographism, and a few scattered solitary urticarial lesions.  There are no respiratory symptoms - specifically no shortness of breath, cough, bronchospasm, swelling of mouth, lips or tongue.  No joint pain.  No fever.   I took zyrtec 10 mg with minimal improvement.  I contacted my dermatologist today who feels this is an Id reaction and suggested reporting the reaction to VAERS.  I have also contacted my primary physician and have a telehealth visit scheduled.  The biggest question is whether to have the second dose of the vaccine, as I am a physician actively seeing sick outpatients.
Approximately one week after having the vaccine in my right arm, I developed parasthesia in my right hand. It was later diagnosed as Raynaud's Syndrome. Prior to the vaccine, I had no history of Raynaud's in that hand. My left hand/arm were unaffected. I continue to have parasthesia, numbness and significant blood vessel constriction on a daily basis in my right hand.
Evening my arm started hurting (injection site arm). Next day, dull pain in my back and arm still hurt. Monday (day 3) the pain moved to my chest - a dull pain. Day 6 I noticed that my throat was tight at end of the day. It didn't hurt; just tight. Friday morning, I woke up feeling chilled. I called Employee Health. They had me tested. I had a low grade fever for a couple of days. I took Motrin. As the week progressed, I had a little cough but bad enough to treat I had a little bit of sinus. I had two days of sinus headache - took Motrin. I had a day (maybe Wednesday) that I got a blister on my eyelid. It irritated my eye. It subsided about two days after. The end of the week, I lost my sense of smell. It took a couple of weeks before that came back.
really bad pain in her right leg /barely any pain in her left leg/pain in the foot; Pain in the ankle; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (really bad pain in her right leg /barely any pain in her left leg/pain in the foot) and ARTHRALGIA (Pain in the ankle) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (really bad pain in her right leg /barely any pain in her left leg/pain in the foot) and ARTHRALGIA (Pain in the ankle). At the time of the report, PAIN IN EXTREMITY (really bad pain in her right leg /barely any pain in her left leg/pain in the foot) and ARTHRALGIA (Pain in the ankle) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications reported. No treatment medications reported.   This case was linked to MOD-2021-304308 (Patient Link).
rash devel @ site of inject also on face & shoulder; no other sx-no distress;
Information has been received from a registered nurse referring to 2 patients of unknown age and gender. There was no pertinent medical history, concomitant medication or drug allergies/drug reactions reported. On 19-AUG-2015, the patients were vaccinated with ZOSTAVAX (0.65 ml, Lot #L016284, expiration date: 07-AUG-2016), which were improperly stored for 6 days. The outcome was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
Headache & Myalgia Narrative:  missed some time from work following  second dose due to symptoms
Fever, headache, chills starting about 12 hours after received vaccine, continuing into the next day
Erythema below injection site 7x6" in diameter down into mid part of the brachium, temp 99.2
This spontaneous report was received from a physician and refers to a currently 20-year-old female patient. The patient's allergies included: morphine, formaldehyde, influenza virus vaccine (unspecified), nickel and bee stings. The patient had any concomitant medication. The patient's pertinent medical history was unknown. On an unknown date in 2007, the patient (9-year-old girl) was vaccinated with an unspecified dose of Oka/Merck VARIVAX, (dose, frequency, route of administration, lot # and expiration date were not reported). On 01-JUN-2018, the patient received an unspecified dose of Oka/Merck VARIVAX, (dose, frequency, route of administration, lot # and expiration date were not reported) as requirement for her job after negative titers (after the previous vaccination). On 01-JUN-2018, the patient experienced left eyelid ptosis, reported as left eye droop, immediately and tingling, itching, macular redness on the arms and legs after 20 minutes of receiving the vaccine. The physician reports that the patient received BENADRYL 50 mg, as an intervention to prevent serious adverse events. The patient was not performed any laboratory tests. At the time of reporting, the patient was still in the physician's office for continued observation. The outcome of antibody negative titers after vaccination was unknown. The outcome of left eyelid ptosis, tingling, itching and macular redness on the arms and legs was reported as not recovered, at the time of this report. The relatedness between the events and the suspect therapy was not reported. The reporter considered the events of left eyelid ptosis, tingling, itching and macular redness on the arms and legs to be medically significant.
It's a little bit hard; Red spot on her arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (It's a little bit hard) and VACCINATION SITE ERYTHEMA (Red spot on her arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE INDURATION (It's a little bit hard) and VACCINATION SITE ERYTHEMA (Red spot on her arm). At the time of the report, VACCINATION SITE INDURATION (It's a little bit hard) and VACCINATION SITE ERYTHEMA (Red spot on her arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant Medications were not provided by the reporter. Treatment Medications were not provided by the reporter.
Patient reports having decrease in coordination, increase brain fog, slow cognitive responses and speech responses. Multiple falls. Lasted 2 days
Information has been received from a physician for GARDASIL, a Pregnancy Registry Product, concerning a 22 year old female with a none history of previous pregnancies, who on 02-AUG-2010, was vaccinated with the first dose of GARDASIL (Lot No: 662404/0312Y). On 17-SEP-2010, the patient was vaccinated with the second dose of GARDASIL (Lot No: 662404/0312Y). Concomitant therapy included vitamins (unspecified) and iron (unspecified). Subsequently, the patient became pregnant. The patient's last menstrual period was on 09-AUG-2010. Estimated delivery date would be on 06-MAY-2011. Follow up information has been received from a physician who reported that on 25-MAY-2011, the patient delivered a healthy normal male baby via C-section full term. The reason for the C-section was not provided. Additional follow up information received from the physician indicated that she checked the records from her clinic and reported that at the time of delivery, which she performed, the baby was "normal". The physician also stated that she was not able to find records of any exams performed to the baby postnatally. Upon internal review, C-section was determined to be an other important medical event. Additional information is not expected.
I am getting headaches, which started about 2 months after the vaccines. They come every day for about an hour or 2, and did not become sporadic until I started taking gabapentin prescribed by my doctor. I had a head MRI done and it was clear, normal for a person my age.
A magnet can now stick to her arm and is very concerned about it; Vaccine administered to 17-year old patient; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (A magnet can now stick to her arm and is very concerned about it) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to 17-year old patient) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (A magnet can now stick to her arm and is very concerned about it) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to 17-year old patient). At the time of the report, VACCINATION SITE REACTION (A magnet can now stick to her arm and is very concerned about it) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to 17-year old patient) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No allergies, current illness, lab data and medical history was reported by patient.  No concurrent and treatment medication was reported by patient.   Patient reported that it was her 1 dose and her 2 dose was due on tomorrow. Patient reported that she was very concerned about it. Patient was not pregnant.
This case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too short in a 63-year-old male patient who received Herpes zoster (SHINGRIX) (batch number unknown, expiry date April 2023) for prophylaxis. Concomitant products included RECOMBINANT VARICELLA ZOSTER VIRUS SURFACE GLYCOPROTEIN E (SHINGRIX). On 7th December 2021, the patient received the 2nd dose of SHINGRIX. On 7th December 2021, unknown after receiving SHINGRIX, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown. Additional details were provided are as follows: Registered nurse reported that a patient received 2nd dose of SHINGRIX was given before recommended minimum interval, which led to shortening of vaccination schedule. The reporter consented to follow-up.
I contracted Covid19 4/8/2022 with symptoms of fatigue, cough, diarrhea, vomiting, fever of 102, brain fog, headache, myalgia, chills, shortness of breathe, chest tightness. I received Monoclonal Antibodies on 04/11/2022 and I was still ill for 10 days. My symptoms of fatigue and cough have lingered.
Hives, went to med center on May 9, Given Prednisone 20mg Decreasing Dose, CompletedDose Hives, went to med center on May 23, Given Prednisone 20m Decreasing Dose, Completed Dose Hives, went to PCP,May 19, Did blood work for respiratory and food allergies and referred to Allergist. Told to start Clairton as well as Benadryl.   Saw Allergist on June 9.  Told to start Clariton 24hr in morning and Benadryl 25mg before bed for 3 months. Talked to nurse for allergist July 1. Hives worsening.  Told to take Benadryl two X's day and continue with Claritin 24 hr daily.
Red, puffy, swollen eyes. Start of symptoms 2 hours later and abated 24 hours later. No treatment other than cool water splashed in eyes.
Breakthrough COVID case: My throat was scratchy and my nose was stuffy. I had a really bad headache. I did take Motrin for my headache. On 01/24/2022 I went to the doctor and was tested for COVID and it came back positive. My symptoms began to get worse. I was producing a ton of saliva which would make me choke. I was also having trouble sleeping I had to sleep upright so that I wouldn't choke on my saliva. I took Dayquil and that didn't help at all. I took Sudafed and that seem to help. I did have a slight fever but that didn't last long. I did experience coughing. My symptoms lasted through 02/07/2022. I did quarantine for another week before going back to work.
Below site of injection large red, swollen, hot, painful area on arm.  One week later still showing pink but no other symptoms.
I had a sore throat, cough, body aches, chills, and fatigue. I went to an urgent care to get tested for COVID-19 and it came back positive. I was not prescribed anything, and I was told to get some rest and take over the counter medication. I still have a cough.
Hives on chest hands and feet, cough, excruciating body aches, body chills, excruciating headache. Tested positive for covid days after receiving vaccine.
patient received the first dose of pfizer covid vaccine and fainted about 15 minutes after receiving the vaccine. patient quickly regained conscious after about 10-15 seconds. patient also felt lightheaded. pharmacist had patient lie down. soon after patient felt fine. patient states this happens often with needle work
About 8 hours after vaccine, sore arm began and has continued to the present time this next morning. About 20 hours after vaccine, this morning, woke up with a fever, chills, nausea, and dizziness. All of these symptoms I am still currently experiencing about 23 hours after the vaccine.
Client given Pfizer Covid vaccine. After administration the client became dizzy, pale and lightheaded. Client assisted to the ground, given O2 @ 10 L via mask, ice pack applied to fore head, feet elevated. Client began to feel better after 2-3 minutes as noted by improvement in skin color,  temperature of skin, verbally stating she was feeling better. Juice and crackers given. Client walked out with mother.
Heart enlarged; This spontaneous case was reported by a patient family member or friend and describes the occurrence of CARDIOMEGALY (Heart enlarged) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced CARDIOMEGALY (Heart enlarged). At the time of the report, CARDIOMEGALY (Heart enlarged) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medications was reported. No treatment drug details was reported.   This case was linked to MOD-2022-594678, MOD-2022-594659 (Patient Link).   Reporter did not allow further contact
Left the recovery room after 15 min and felt fine. Upon getting into car she felt tightness and pressure  in throat and sides of face as well as slight tingling in lips. Came back into recovery room. 911 called and transported to Hospital with EMTs at 11:10. Pulse 87,    BP=164/88 and pulse ox=98.
This case was reported by a nurse via call center representative and described the occurrence of injection site itching in a 64-year-old female patient who received SHINGRIX (batch number TP5E5, expiry date 15th November 2020) for prophylaxis. Concomitant products included fluoxetine hydrochloride (Prozac) and budesonide + formoterol fumarate (Symbicort). On 5th June 2018, the patient received the 1st dose of SHINGRIX (subcutaneous) .5 ml. On 5th June 2018, less than a day after receiving SHINGRIX, the patient experienced injection site itching, injection site swelling, injection site erythema, injection site pain and intramuscular formulation administered by other route. On an unknown date, the outcome of the injection site itching, injection site swelling and injection site erythema were not recovered/not resolved and the outcome of the injection site pain was recovering/resolving and the outcome of the intramuscular formulation administered by other route was unknown. It was unknown if the reporter considered the injection site itching, injection site swelling, injection site erythema and injection site pain to be related to SHINGRIX. Additional details were provided as follows: During the assessment of the patient's arm, it was determined that, the SHINGRIX vaccine was given subcutaneously in the back of the patient's right arm, which led to Inappropriate route of vaccination. The patient experienced injection site reactions, described as, itching, swelling, redness and pain.